Current stem cell therapies face hurdles like lengthy autologous processes and donor-host matching. #CRISPR-edited hESCs show promise in vitro but face rejection in vivo. Daily biotech insights 👉🏼 @gathersight. https://t.co/vPJPFasx1E https://t.co/iINaDilo
84 followers
1,799 followers
“#CRISPR-Cas9 immune-evasive hESCs are rejected following transplantation into immunocompetent mice” Frederiksen HR [..] Doehn U. Front Genome Ed. 2024-05-28. https://t.co/0ol6vdLUdQ
5,561 followers
New Research: New Research: CRISPR-Cas9 immune-evasive hESCs are rejected following transplantation into immunocompetent mice https://t.co/zbaNWboTPG #FrontiersIn #GenomeEditing